4-bromo-1H-pyrrolo[2,3-b]pyridin-6-amine


Chemical Name: 4-bromo-1H-pyrrolo[2,3-b]pyridin-6-amine
CAS Number: 943323-55-5
Product Number: AG006BYG(AGN-PC-09RUXD)
Synonyms:
MDL No:
Molecular Formula: C7H6BrN3
Molecular Weight: 212.0466

Identification/Properties


Properties
Storage:
2-8℃;Light sensitive;Keep in dry area;
Form:
Solid
Computed Properties
Molecular Weight:
212.05g/mol
XLogP3:
1.7
Hydrogen Bond Donor Count:
2
Hydrogen Bond Acceptor Count:
2
Rotatable Bond Count:
0
Exact Mass:
210.975g/mol
Monoisotopic Mass:
210.975g/mol
Topological Polar Surface Area:
54.7A^2
Heavy Atom Count:
11
Formal Charge:
0
Complexity:
153
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



4-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine is a key building block in chemical synthesis due to its versatile reactivity and unique structural properties. It serves as a valuable intermediate in the synthesis of various complex molecules, including pharmaceuticals, agrochemicals, and materials.This compound can participate in a variety of organic reactions, such as Suzuki coupling, Buchwald-Hartwig amination, and cross-coupling reactions, allowing for the efficient construction of diverse molecular structures. Its halogen atom enables further functionalization, making it highly customizable for specific synthetic needs.In medicinal chemistry, 4-Bromo-1H-pyrrolo[2,3-b]pyridin-6-amine is often utilized in the development of novel drug candidates, particularly in the design of kinase inhibitors and bioactive compounds. Its incorporation into molecular frameworks can enhance biological activity and improve drug-like properties.Furthermore, this compound's pyrrolopyridine scaffold imparts unique physicochemical characteristics, such as aromaticity and hydrogen bonding capabilities, which contribute to its utility in the creation of molecular libraries for screening and lead optimization in drug discovery programs.